Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Merck KGaA
  6. News
  7. Press Releases
    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société MERCK KGAA
05/25MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
05/21MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
05/20MERCK  : Bionity- Merck Announces Changes in Operating Model for Healthcare Busi..
AQ
05/19MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
05/07MERCK  : ALJ Bullock Grants-in-Part Motion For Summary Determination Of Violatio..
AQ
05/04MERCK  : raises forecast for full year 2021
EQ
05/04MERCK  : foundation partner with Africa Reproductive Care Society (ARCS) to buil..
AQ
05/04MERCK  : foundation partner with Africa Reproductive Care Society (ARCS) to buil..
AQ
04/30MERCK  : Zambia President and Prof. Dr. Frank Stangenberg-Haverkamp inaugurate t..
AQ
04/29MERCK  : BAVENCIO Receives Reimbursement Recommendation from pCODR and INESSS fo..
AQ
04/29MERCK  : Zambia President, H.E. Dr. EDGAR CHAGWA LUNGU inaugurates the 8th editi..
AQ
04/28MERCK  : Zambia President, H.E. Dr. EDGAR CHAGWA LUNGU inaugurates the 8th editi..
AQ
04/28MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
04/28MERCK  : EMD Serono Announces New Data Strengthening Evidence for Use of MAVENCL..
AQ
04/26EMD Serono - New Data Strengthening Evidence for Continued Safe and Effective..
AQ
04/26MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
04/22MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
04/19MERCK  : EMD Serono, Inc. - Evobrutinib is the First and Only BTK Inhibitor to D..
AQ
04/13MERCK  : Sustainability Report 2020 PDF
PU
04/13MERCK  : SASB Report
PU
03/25MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
03/23MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
03/17MERCK  : MilliporeSigma Accelerates European Expansion Plans for Single-use Prod..
AQ
03/12MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
03/11MERCK  : Explanations on the submission of statements
PU
03/04MERCK  : Corporate Governance Statement 2020 (Version March 2021)
PU
02/19CIRCA GROUP AS : NOK 575 million private placement successfully completed
AQ
02/17MERCK  : Embracing Carers Global Study Shows Covid-19 Has Taken a Significant To..
AQ
02/17MERCK KGAA : Preliminary announcement of the publication of quarterly reports an..
EQ
02/17MERCK KGAA : Preliminary announcement of the publication of financial reports ac..
EQ
02/10MERCK  : EMD Serono - Real-World Evidence Study at Miami CFAR Suggests HIV-Assoc..
AQ
02/094D pharma announces clinical trial collaboration with Merck KGaA and Pfizer t..
AQ
02/084D pharma announces clinical trial collaboration and supply agreement with Me..
AQ
02/05MERCK  : Announces Leadership Change for North America and Global Innovative Med..
AQ
02/05MERCK KGAA  : Darmstadt, Germany, Announces Leadership Change for North America ..
AQ
02/04MERCK  : EMD Serono - FDA Approves TEPMETKO as the First and Only Once-daily Ora..
AQ
01/28MERCK  : Diethyl Oxalate Market to reach US$ 891.93 Mn by 2027 - Borsodchem MCHZ..
AQ
01/26PFIZER  : EMD Serono - European Commission Approves BAVENCIO for First-Line Main..
AQ
01/20MERCK KGAA : Merck KGaA to discontinue bintrafusp alfa clinical trial (INTR@PID ..
EQ
01/11MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
01/11MERCK  : Health Canada Approves BAVENCIO® for the Maintenance Treatment of Patie..
AQ
01/07MERCK  : MilliporeSigma Acquires AmpTec to Expand mRNA Capabilities for Vaccines..
AQ
01/06MERCK  : EMD Serono Appoints Manuel Zafra as New Managing Director for Canada
AQ
2020MERCK KGAA  : Notification and public disclosure of transactions by persons
EQ
2020PFIZER  : EMD Serono - BAVENCIO Receives Positive CHMP Opinion for First-Line Ma..
AQ
2020ARIX BIOSCIENCE  : Artios and Merck KGaA announce global strategic collaboration
AQ
2020Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations..
AQ
2020MERCK KGAA : Correction of a release from 25/03/2020 according to Article 40, Se..
EQ
2020MERCK  : Massachusetts-based Businesses of Merck KGaA, Darmstadt, Germany named ..
AQ
2020MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
2020MERCK  : EMD Serono's Embracing Carers Announces Study Results on COVID-19 and C..
AQ
2020International companies to host live webcasts at Deutsche Bank's Depositary R..
AQ
2020MERCK  : MIT - Innovative face masks and medical-grade gowns to combat Covid-19 ..
AQ
2020MASSACHUSETTS INSTITUTE OF TECHNOLOG : Innovative face masks and medical-grade g..
AQ
2020MERCK  : MAVENCLAD® (cladribine tablets) is available through public drug plans ..
AQ
2020Global Glycobiology Market to Rise at 14.64% between 2020 and 2027
AQ
2020MERCK  : MilliporeSigma Celebrates Topping-Out Ceremony for New Membrane Product..
AQ
2020MERCK KGAA  : - MilliporeSigma Inaugurates New, Upgraded Onsite Industrial Water..
AQ
2020PFIZER  : When Are Recombinant Proteins Structurally Different Than Their Natura..
AQ
2020BIOGEN  : Merck - Press Release as a Result of the Ad-hoc Announcement of Septem..
AQ
2020MERCK KGAA : Merck KGaA reverses provision for lawsuit in the amount of EUR 365 ..
EQ
2020IPSEN  : appoints Philippe Lopes-Fernandes as Executive Vice President, Chief Bu..
AQ
2020MERCK  : Darmstadt, Germany, Opens State-of-the-art Research Center for Electron..
PU
2020MERCK  : Agenda
PU
2020MERCK  : BAVENCIO Pivotal Phase III JAVELIN Bladder 100 Results Published in The..
PU
2020MERCK KGAA  : Darmstadt, Germany Announces Positive Phase II Results for Investi..
AQ
2020MERCK  : Darmstadt, Germany, Advances Oncology Portfolio and Pipeline with New a..
PU
2020MERCK  : Darmstadt, Germany Announces Positive Phase II Results for Investigatio..
PU
2020MERCK  : Darmstadt, Germany, Announces € 59 Million Antibody-Drug Conjugate Manu..
PU
2020MERCK  : EMD Serono to Showcase New Data at ACTRIMS-ECTRIMS MSVirtual2020 Meetin..
AQ
2020MERCK  : Darmstadt, Germany to Showcase New Data at ACTRIMS-ECTRIMS MSVirtual202..
PU
2020MERCK  : FDA Accepts Filing of New Drug Application for Tepotinib for the Treatm..
AQ
2020SUTRO BIOPHARMA  : Earns Clinical Supply Milestone Payment from Merck KGaA, Darm..
AQ
2020Growing R&D Activities to Push the Global Protein Expression Market to Garner..
AQ
2020MERCK  : Q2 2020 Financial Summary for Investors and Analysts
PU
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on MERCK KGAA